However, the deaths of 4 patients were considered by the study investigator to be related to treatment with clofarabine: one patient experienced clofarabine-related acute vascular leak syndrome that contributed to cardiac arrest; one patient died from respiratory distress and hepatocellular damage; one patient from septic shock and multi-organ failure; and one patient from multi-organ failure.